Drugs with this side effect
- 4-AP
- 4-methylpyrazole
- 5-ASA: postmarketing, 2% - 3%
- 5-aza-2'-deoxycytidine: 9.09% - 10.8%
- 5-azacytidine: common, 0% - 13.2%
- A77 1726: 4% - 4.19%
- BCNU: 6.67%
- BPTI
- Bivalirudin: 5.88% - 6.51%
- CGP 19835A: common
- Cancidas
- Colimycin M
- D-penicillamine
- Enfuvirtide: 6.8% - 7.5%
- FK463: 0% - 23.3%
- Forteo
- Gd-DTPA
- Glat copolymer
- Goserelin: 1-10%
- ICI 182,780: 3.8% - 5%
- Implanon: postmarketing
- Insulin
- K779: 1% - 47%
- L-Dmp
- LY146032: postmarketing, common, 5% - 5.2%
- Leuprorelin
- Lisinopril
- MDV3100: 0.3% - 6.5%
- Madopar
- Meropenem anhydrous
- Mersyndol
- Metrodin
- NovoLog
- NuvaRing
- Octreotide: 0.5-3%
- Oestrogen: 0.618% - 5.7%
- PCI-32765
- Photofrin: 0% - 7%
- Photofrin II: common
- Protirelin
- SOM230: 6.1% - 11.2%
- Sativex
- Signifor: 6.1% - 11.2%
- Stalevo 50
- Supremon: 1.19%
- Triptorelin
- Trisequens
- Vitrum: 1%
- Zyprexa Relprevv
- abacavir: 3.12% - 5.18%
- acamprosate: 5% - 8%
- acebutolol
- acetaminophen
- acetohydroxamic acid
- acitretin: postmarketing
- agomelatine
- almotriptan: infrequent
- alosetron: infrequent
- alpha-methyl-p-tyrosine
- alprazolam: 1.1% - 16.6%
- amantadine: postmarketing, uncommon, common
- aminophylline
- amisulpride: common, 7% - 9%
- amitriptyline
- amlodipine
- amlodipine besylate
- amobarbital
- amoxicillin: postmarketing
- amphetamine
- amphotericin B: 11% - 13.7%
- anastrozole: 5% - 6.31%
- anthracycline
- apomorphine
- aprepitant: 0% - 0.5%
- aripiprazole: 1% - 25%
- arsenic
- arsenic trioxide
- asenapine: 1.1% - 4%
- atazanavir: uncommon
- atenolol: postmarketing
- atomoxetine: postmarketing
- atovaquone: 7% - 10%
- atropine
- azelastine
- azithromycin: postmarketing
- baclofen: common, 0.2% - 0.9%
- benazepril
- benazeprilat
- bendamustine
- benzathine penicillin
- bepridil
- betaxolol: postmarketing
- bexarotene
- bicalutamide
- bicarbonate
- bimatoprost
- bisoprolol
- boceprevir: very common, 6%
- bortezomib: 0% - 14%
- bosentan
- bretylium
- brimonidine
- bromocriptine
- budesonide: postmarketing
- bupivacaine: 0.982% - 1.32%
- buprenorphine: 10.8% - 13.8%
- bupropion: 0.8% - 9%
- busulfan: 65% - 75%
- butabarbital
- butorphanol
- cabazitaxel
- cabergoline: 1% - 11.1%
- cabozantinib: 0% - 9%
- candesartan
- candesartan cilexetil
- capecitabine
- carbamazepine: 7%
- carbidopa
- carboprost
- carnitine: 1% - 2%
- cefaclor
- cefpodoxime
- ceftobiprole
- celecoxib
- cerivastatin
- cetirizine
- cevimeline: 1.3%
- chloroprocaine
- chloroquine
- chlorpheniramine
- cidofovir
- cilazapril
- cilostazol
- cimetidine
- ciprofloxacin: postmarketing, rare
- citalopram: postmarketing, 2.9% - 5.3%
- cladribine: common, 1%
- clarithromycin: postmarketing
- clindamycin phosphate
- clobazam: postmarketing
- clofarabine: very common, 12%
- clomiphene citrate: postmarketing
- clomipramine: common, 2% - 9%
- clonazepam
- clonidine: 0% - 2%
- clopidogrel
- clozapine: 1%
- codeine
- colestyramine
- copolymer 1
- cortisol
- cyanocobalamin
- cyclobenzaprine
- cytarabine: 3.03% - 10.7%
- danazol
- darunavir
- dasatinib
- deferasirox: uncommon
- delamanid
- delavirdine
- delta 9-THC
- demethyl
- deprenyl: postmarketing, 1%
- desipramine
- desmopressin: 0.05%
- desvenlafaxine: 3% - 5%
- dexamethasone
- dexamethasone sodium phosphate
- dexmedetomidine
- diazoxide
- diclofenac: very rare, 0% - 2%
- diethylpropion
- digoxin
- dihydroergotamine: postmarketing, rare
- dimercaprol
- dipyridamole: 0.2%
- dofetilide
- dolasetron
- donepezil: frequent
- dopamine
- dorzolamide
- dothiepin
- doxazosin: 1% - 2.3%
- doxepin: infrequent
- doxorubicin: common
- doxycycline
- droperidol
- duloxetine: common, frequent, 3%
- efavirenz: common, 0% - 4%
- eletriptan: infrequent
- emtricitabine
- entacapone: 2%
- ephedrine
- eprosartan
- erlotinib: 21%
- ertapenem
- esmolol
- estazolam: frequent
- estradiol: postmarketing, 0% - 10%
- estradiol valerate
- estramustine: 0% - 1%
- estramustine phosphate
- etodolac: postmarketing
- etoricoxib
- etravirine
- everolimus: very common, 0% - 21%
- exemestane: 4.1% - 11%
- exenatide: 0.606% - 2.07%
- famciclovir: 0% - 1.23%
- famotidine
- febuxostat
- felbamate: 2% - 5.3%
- fenofibrate
- fenoldopam
- fentanyl: very rare, postmarketing, common, 0% - 15%
- flecainide
- florbetapir: 0.4%
- flumazenil
- flunisolide
- flunitrazepam: rare
- fluoxetine: frequent, very common, 1% - 16.3%
- fluoxymesterone
- flurbiprofen
- flutamide
- fluticasone: postmarketing
- fluticasone propionate: very rare
- fluticasone/salmeterol: uncommon
- fluvastatin: postmarketing
- fluvoxamine: common, frequent, 1% - 9.4%
- fondaparinux: rare, 0.727% - 0.785%
- formoterol: uncommon, 1.5%
- fosaprepitant
- fosaprepitant dimeglumine: 0% - 0.5%
- foscarnet
- frovatriptan: frequent
- gabapentin: postmarketing, infrequent, frequent
- gadobenate dimeglumine: postmarketing
- gadodiamide
- gadofosveset
- gadolinium
- gadopentetate
- gadoteridol: 0.17%
- gadoversetamide
- galantamine
- ganciclovir: 1.7% - 2.4%
- gatifloxacin
- gliclazide
- glimepiride
- glipizide
- granisetron: common, 2% - 3.4%
- guanfacine: postmarketing
- haloperidol
- histamine
- hydralazine: uncommon
- hydrochlorothiazide
- hydrocodone
- hydromorphone: 0% - 3.84%
- hydroxybutyrate: 1% - 2%
- ibandronate
- ibuprofen
- icodextrin
- imatinib: infrequent, uncommon, 0% - 12%
- imipramine: common
- imiquimod: 1% - 1.1%
- indapamide
- indinavir
- indomethacin
- insulin detemir
- iodixanol
- iopamidol
- iopromide: 0.3%
- iotrolan
- ioversol
- irbesartan: 0.5% - 1.7%
- irbesartan-hydrochlorothiazide: 0.5% - 1.7%
- iron sucrose
- isomannide
- isosorbide-5-mononitrate
- isradipine
- itraconazole
- ketoprofen
- ketorolac
- ketorolac tromethamine: postmarketing
- lamivudine
- lamotrigine: 0% - 5%
- lanreotide
- lansoprazole
- leflunomide: postmarketing, uncommon
- lenalidomide: common
- lercanidipine
- letrozole: uncommon
- leuprorelin acetate: 0% - 3%
- levetiracetam: 1.6% - 3.33%
- levodopa/carbidopa
- levonorgestrel
- lisdexamfetamine dimesylate: 6%
- lisuride
- lomefloxacin
- lorcaserin: 3.52%
- lormetazepam
- losartan
- lovastatin: postmarketing
- lubiprostone
- lurasidone: 3% - 7%
- maprotiline: 3%
- medroxyprogesterone
- medroxyprogesterone acetate
- mefenamic acid
- mefloquine: postmarketing
- melatonin
- meloxicam
- memantine: 2.63% - 4%
- meperidine
- mepivacaine
- meropenem
- mesna: 3.4% - 7%
- methadone
- methohexital
- methylene blue
- methylphenidate: postmarketing, common, 0.7% - 11%
- methylprednisolone
- methylprednisolone sodium succinate
- methyltestosterone
- metipranolol
- metoclopramide
- metolazone
- metoprolol: postmarketing, rare
- midazolam
- midodrine
- mifepristone: 10%
- milnacipran: 3% - 5%
- mirtazapine: postmarketing, frequent
- misoprostol: postmarketing
- mitoxantrone: 5%
- moclobemide
- modafinil: postmarketing, 4%
- moexiprilat
- montelukast: postmarketing
- morphine: 5% - 6%
- moxifloxacin
- moxonidine: postmarketing
- mycophenolate mofetil: 17.8% - 28.4%
- mycophenolic acid: 23.9% - 28.4%
- nabilone: postmarketing
- nabumetone: 0.4%
- nalbuphine
- naltrexone: postmarketing, 2%
- naproxen
- naratriptan: infrequent
- nefazodone
- nelfinavir
- nicardipine
- nicotine
- nifedipine
- nilotinib: uncommon, common
- nisoldipine
- nitrazepam
- nitrite
- nizatidine: 1.6%
- norepinephrine
- norfloxacin
- nortriptyline: rare
- o291: 0.171%
- ofloxacin
- olanzapine: postmarketing, 9%
- olmesartan: 0.171% - 1.03%
- omeprazole: postmarketing
- ondansetron: 2.01% - 6.49%
- orlistat: uncommon, 2.8% - 4.7%
- oseltamivir: postmarketing
- oxaliplatin: 0% - 6%
- oxaprozin
- oxcarbazepine: 5% - 7%
- oxybutynin
- oxycodone
- oxymorphone
- paclitaxel
- paliperidone: 0% - 9%
- palonosetron
- pamidronate: 0% - 18%
- pantoprazole: very rare
- paricalcitol: 2% - 3.3%
- paroxetine: postmarketing, common, 0% - 5.9%
- penicillin
- pentamidine
- pentobarbital
- pentostatin
- pentoxifylline
- perampanel: 2% - 4%
- pergolide: frequent, 6.4%
- perindopril
- perindopril erbumine
- phenelzine
- phenylpropanolamine
- pilocarpine
- pindolol
- pirbuterol
- piroxicam
- pixantrone
- pomalidomide: 7.14% - 11.2%
- posaconazole
- potassium phosphate
- pramipexole
- pravastatin: 1% - 4.8%
- prednisolone phosphate
- prednisone
- pregabalin: frequent, 2%
- procaine
- procaine penicillin
- progesterone
- promethazine
- propafenone: postmarketing, 0.5% - 11.8%
- propofol
- prostacyclin: 9% - 21%
- protriptyline
- quetiapine: 2% - 4%
- rabeprazole
- raltegravir: postmarketing
- ramipril
- ramiprilat
- ranolazine
- rapamycin
- rasagiline: frequent
- rasburicase: 0% - 23.9%
- reboxetine: postmarketing, 4.44%
- regadenoson: uncommon
- remifentanil: 0% - 3.41%
- reserpine
- retigabine: 2% - 5%
- retinoic acid: postmarketing, 17%
- ribavirin: common, very common, 10% - 38%
- rifapentine
- rilpivirine
- riluzole
- rimantadine
- rimonabant
- risedronate: 1.3% - 2.3%
- risperidone: frequent, 0% - 20%
- ritonavir: 0% - 1.7%
- rivastigmine: common, 1% - 5%
- rizatriptan: infrequent
- rofecoxib
- roflumilast
- ropinirole: frequent, 1.9% - 6%
- ropivacaine: 0.2% - 4%
- rufinamide: 3%
- salbutamol: 0% - 2.7%
- salmeterol
- salmon calcitonin acetate
- saquinavir
- secobarbital
- sertraline: postmarketing, rare, common, 2% - 4%
- sibutramine
- sildenafil: postmarketing
- simvastatin
- sitagliptin
- sodium
- sodium cromoglycate
- sofosbuvir: common
- sotalol: 1% - 4%
- sparfloxacin
- stavudine: uncommon
- sumatriptan: rare, frequent
- tacrolimus
- tamoxifen: 5.82% - 6.31%
- tapentadol: 1% - 5%
- teduglutide
- telavancin: uncommon
- telithromycin
- telmisartan: rare, common
- temazepam: 1.5% - 2%
- temozolomide: common, 0.633% - 6.96%
- temsirolimus
- tenofovir
- tenofovir disoproxil fumarate
- terazosin
- terbinafine: postmarketing
- terbutaline: 1%
- testosterone: postmarketing, uncommon
- testosterone enanthate: postmarketing
- testosterone propionate
- testosterone undecanoate
- tetrabenazine
- tetraen
- thalidomide: 0% - 25.5%
- theophylline
- thiotepa
- thyroxine
- tiagabine
- tiaprofenic acid
- timolol: postmarketing
- tizanidine: frequent
- tolcapone
- tolterodine
- topiramate: 0% - 10.4%
- tramadol: postmarketing, rare
- trandolapril
- trandolaprilat
- tranylcypromine
- travoprost
- trazodone: postmarketing
- treprostinil
- triamcinolone acetonide
- triazolam
- trimethoprim: very rare
- trimipramine
- trovafloxacin
- ustekinumab
- v 1784: postmarketing
- valdecoxib
- valganciclovir
- valproate
- valsartan
- vandetanib
- vardenafil
- varenicline: postmarketing, frequent
- venlafaxine: postmarketing, 1% - 11.2%
- vigabatrin: 0% - 4%
- vinflunine
- voriconazole: common
- zalcitabine
- zaleplon: frequent
- zanamivir: postmarketing
- ziconotide: 8%
- zidovudine: postmarketing, rare
- zidovudine/lamivudine
- ziprasidone: uncommon, 0% - 5%
- zoledronic acid: uncommon, 8% - 12%
- zolmitriptan: infrequent
- zolpidem: infrequent, 1% - 3%
- zonisamide: 3%
- zopiclone: 1% - 3%
- zuclopenthixol
|
Drugs with this indication
|